Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection

American Journal of Roentgenology

Volumn 188, Issue 1, 2007, Pages 91-98

  Reinsberg, Stefan A ^a   Payne, Geoffrey S ^a   Riches, Sophie F ^a   Ashley, Sue ^b   Brewster, Jonathan M ^b   Morgan, Veronica A ^a   DeSouza, Nandita M ^a,b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Diffusion weighted MRI; Genitourinary tract imaging; MR spectroscopy; MR technique; MRI; Oncologic imaging; Prostate cancer

Indexed keywords

CHOLINE; CITRIC ACID; PROSTATE SPECIFIC ANTIGEN; SCOPOLAMINE BUTYL BROMIDE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERISTALSIS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL ANALYSIS;

AGED; DIAGNOSIS, COMPUTER-ASSISTED; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROSTATIC NEOPLASMS; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33845792481     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.05.2198     Document Type: Article

References (29)

1. Kwek JW, Thug CH, Tan PH, et al. Phased-array magnetic resonance imaging of the prostate with correlation to radical prostatectomy specimens: local experience. Asian J Surg 2004; 27:219-224
2. Nakashima J, Tanimoto A, Imai Y, et al. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 2004; 64:101-105
3. Ikonen S, Karkkainen P, Kivisaari L, et al. Magnetic resonance imaging of clinically localized prostatic cancer. J Urol 1998; 159:915-919
4. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 1999; 213:473-480
5. Swanson MG, Vigneron DB, Tabatabai ZL, et al. Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med 2003; 50:944-954
6. Yuen JS, Thng CH, Tan PH, et al. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 2004; 171:1482-1486
7. Casciani E, Polettini E, Bertini L, et al. Prostate cancer: evaluation with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiol Med (Torino) 2004; 108:530-541
8. Shimofusa R, Fujimoto H, Akamata H, et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 2005; 29:149-153
9. Hosseinzadeh K, Schwarz SD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 2004; 20:654-661
10. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 2002; 16:196-200
11. Star-Lack J, Nelson SJ, Kurhanewicz J, Huang LR, Vigneron DB. Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 1997; 38:311-321
12. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30:672-679
13. Mullerad M, Hricak H, Wang L, Chen HN, Kattan MW, Scardino PT. Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology 2004; 232:140-146
14. D'Amico AV, Schnall M, Whittington R, et al. Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease. Urology 1998; 51:449-454
15. Mangar SA, Huddart RA, Parker CC, Dearnaley DP, Khoo VS, Horwich A. Technological advances in radiotherapy for the treatment of localised prostate cancer. Eur J Cancer 2005; 41:908-921
16. Susil RC, Camphausen K, Choyke P, et al. System for prostate brachytherapy and biopsy in a standard 1.5 TMRI scanner. Magn Reson Med 2004; 52:683-687
17. Xiao Z, Tamimi Y, Brown K, Tulip J, Moore R. Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-aminolevulinic acid. Urol Oncol 2002; 7:125-132
18. Prepelica KL, Okeke Z, Murphy A, Katz AE. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer 2005; 103:1625-1630
19. Hasumi M, Suzuki K, Oya N, et al. MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer. Anticancer Res 2002; 22:1205-1208
20. Hasumi M, Suzuki K, Taketomi A, et al. The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer. Anticancer Res 2003; 23:4223-4227
21. Wefer AE, Hricak H, Vigneron DB, et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000; 164:400-404
22. 1H magnetic resonance spectroscopic imaging. Magn Reson Med 2000; 43:17-22
23. Zakian KL, Sircar K, Hricak H, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005; 234:804-814
24. Jennings D, Hatton BN, Guo J, et al. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia 2002; 4:255-262
25. Artemov D, Pilatus U, Chu S, Mori N, Nelson JB, Bhujwalla ZM. Dynamics of prostate cancer cell invasion studied in vitro by NMR microscopy. Magn Reson Med 1999; 42:277-282
26. Song SK, Garabedian EM, Gordon JI, Milbrandt J, Ackerman JJ. Improved magnetic resonance imaging detection of prostate cancer in a transgenic mouse model. Cancer Res 2002; 62:1555-1558
27. deSouza NM, Reinsberg SA, Brewster JM, et al. Diffusion weighted endorectal imaging of the prostate: differentiation of malignant from benign regions. (abstr) Proc Intl Soc Mag Reson Med 2005; 13:2124
28. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005; 21:258-262
29. Ikonen S, Kivisaari L, Tervahartiala P, Vehmas T, Taari K, Rannikko S. Prostatic MR imaging: accuracy in differentiating cancer from other prostatic disorders. Acta Radiol 2001; 42:348-354